Assessment of Confirmed Clinical Hypersensitivity to Rituximab in Patients Affected with B-Cell Neoplasia

Rituximab hypersensitivity reactions are rare but are one of the main causes of rituximab elimination from antilymphoma immunochemotherapy treatments. While the clinical picture may be indistinguishable from other infusion-related reactions, hypersensitivity reactions (HSR) do not disappear and inst...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Adv Hematol
Main Authors: Novelli, S., Soto, L., Caballero, A., Moreno, M. E., Lara, M. J., Bayo, D., Quintas, A., Jimeno, P., Zamora, M. I., Bigorra, T., Sierra, J., Briones, J.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2020
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7305539/
https://ncbi.nlm.nih.gov/pubmed/32577119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/4231561
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados